Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Pharmaceutical Biotechnology
|
January 1, 1996
In vitro viable skin model
R L Bronaugh
Annals of the New York Academy of Sciences
|
November 18, 2000
In vitro percutaneous absorption models
R L Bronaugh
Psychopharmacology Communications
|
January 1, 1975
The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity
R L Bronaugh, M Goldstein
Journal of Pharmaceutical Sciences
|
May 1, 1986
Methods for in vitro percutaneous absorption studies. VI: Preparation of the barrier layer
R L Bronaugh, R F Stewart
The Journal of Investigative Dermatology
|
March 1, 1985
Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkey
R L Bronaugh, H I Maibach
Journal of Pharmaceutical Sciences
|
September 1, 1984
Methods for in vitro percutaneous absorption studies III: hydrophobic compounds
R L Bronaugh, R F Stewart
Toxicology and Applied Pharmacology
|
June 30, 2000
Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin
J J Yourick, R L Bronaugh
Journal of Neurochemistry
|
October 1, 1973
Partial purification and characterization of NADPH-linked aldehyde reductase from monkey brain
R L Bronaugh, V G Erwin
The Journal of Investigative Dermatology
|
August 1, 1984
Percutaneous absorption of hair dyes: correlation with partition coefficients
R L Bronaugh, E R Congdon
Biochemical Pharmacology
|
May 15, 1972
Further characterization of a reduced nicotinamide-adenine dinucleotide phosphate-dependent aldehyde reductase from bovine brain. Inhibition by phenothiazine derivatives
R L Bronaugh, V G Erwin
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Pharmaceutical Biotechnology
|
January 1, 1996
In vitro viable skin model
R L Bronaugh
Annals of the New York Academy of Sciences
|
November 18, 2000
In vitro percutaneous absorption models
R L Bronaugh
Psychopharmacology Communications
|
January 1, 1975
The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity
R L Bronaugh, M Goldstein
Journal of Pharmaceutical Sciences
|
May 1, 1986
Methods for in vitro percutaneous absorption studies. VI: Preparation of the barrier layer
R L Bronaugh, R F Stewart
The Journal of Investigative Dermatology
|
March 1, 1985
Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkey
R L Bronaugh, H I Maibach
Journal of Pharmaceutical Sciences
|
September 1, 1984
Methods for in vitro percutaneous absorption studies III: hydrophobic compounds
R L Bronaugh, R F Stewart
Toxicology and Applied Pharmacology
|
June 30, 2000
Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin
J J Yourick, R L Bronaugh
Journal of Neurochemistry
|
October 1, 1973
Partial purification and characterization of NADPH-linked aldehyde reductase from monkey brain
R L Bronaugh, V G Erwin
The Journal of Investigative Dermatology
|
August 1, 1984
Percutaneous absorption of hair dyes: correlation with partition coefficients
R L Bronaugh, E R Congdon
Biochemical Pharmacology
|
May 15, 1972
Further characterization of a reduced nicotinamide-adenine dinucleotide phosphate-dependent aldehyde reductase from bovine brain. Inhibition by phenothiazine derivatives
R L Bronaugh, V G Erwin
Page
of 5